T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Arista Networks
ANET
|
+$4.06B |
| 2 |
Oracle
ORCL
|
+$2.93B |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$2.35B |
| 4 |
Apple
AAPL
|
+$2.27B |
| 5 |
Caterpillar
CAT
|
+$2.12B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$3.44B |
| 2 |
Eli Lilly
LLY
|
+$2.51B |
| 3 |
Microsoft
MSFT
|
+$2.39B |
| 4 |
FISV
Fiserv Inc
FISV
|
+$2.2B |
| 5 |
Norfolk Southern
NSC
|
+$1.97B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 36.3% |
| 2 | Financials | 11.67% |
| 3 | Consumer Discretionary | 10.88% |
| 4 | Communication Services | 10.76% |
| 5 | Healthcare | 9.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1801
La-Z-Boy
LZB
$1.67B
| $1.67M | ﹤0.01% |
48,772
+1,438
| +3% | +$52.7K |
|
1802
Trump Media & Technology Group
DJT
$2.32B
| $1.67M | ﹤0.01% |
101,647
+29,425
| +41% | +$522K |
|
1803
Enovis
ENOV
$1.49B
| $1.67M | ﹤0.01% |
54,909
+6,951
| +14% | +$211K |
|
1804
Federated Hermes
FHI
$4.74B
| $1.66M | ﹤0.01% |
32,010
| – | – |
|
1805
GoodRx Holdings
GDRX
$1.26B
| $1.66M | ﹤0.01% |
391,425
+134,771
| +53% | +$592K |
|
1806
Novavax
NVAX
$1.31B
| $1.66M | ﹤0.01% |
191,066
+7,921
| +4% | +$61.6K |
|
1807
Arcutis Biotherapeutics
ARQT
$3.23B
| $1.66M | ﹤0.01% |
87,802
+3,755
| +4% | +$59.2K |
|
1808
Ashland
ASH
$3.35B
| $1.65M | ﹤0.01% |
34,331
+2,031
| +6% | +$107K |
|
1809
PagerDuty
PD
$921M
| $1.63M | ﹤0.01% |
98,478
-3,077
| -3% | -$48.9K |
|
1810
iShares Core S&P Mid-Cap ETF
IJH
$128B
| $1.63M | ﹤0.01% |
24,916
| – | – |
|
1811
Tennant Co
TNC
$1.18B
| $1.61M | ﹤0.01% |
19,922
+734
| +4% | +$60K |
|
1812
Energizer
ENR
$1.57B
| $1.61M | ﹤0.01% |
64,845
+2,349
| +4% | +$61.4K |
|
1813
Worthington Enterprises
WOR
$2.89B
| $1.61M | ﹤0.01% |
29,077
+1,114
| +4% | +$70.2K |
|
1814
NCR Voyix
VYX
$1.14B
| $1.61M | ﹤0.01% |
128,048
+8,295
| +7% | +$109K |
|
1815
Vanguard Morningstar Growth ETF
VUG
$230B
| $1.6M | ﹤0.01% |
20,046
+474
| +2% | +$36.2K |
|
|
AVDX
1816
DELISTED
AvidXchange
AVDX
| $1.6M | ﹤0.01% |
160,682
+8,918
| +6% | +$88.2K |
|
1817
Intellia Therapeutics
NTLA
$1.65B
| $1.6M | ﹤0.01% |
92,511
+41,377
| +81% | +$510K |
|
1818
iShares MSCI Canada ETF
EWC
$6.55B
| $1.59M | ﹤0.01% |
31,451
| – | – |
|
1819
Patterson-UTI
PTEN
$4.32B
| $1.59M | ﹤0.01% |
306,920
-246,127
| -45% | -$1.42M |
|
1820
John Wiley & Sons Class A
WLY
$2.61B
| $1.59M | ﹤0.01% |
39,279
+1,517
| +4% | +$61.2K |
|
1821
TriCo Bancshares
TCBK
$1.85B
| $1.59M | ﹤0.01% |
35,773
+810
| +2% | +$35.2K |
|
1822
Cohen & Steers
CNS
$4.38B
| $1.58M | ﹤0.01% |
24,071
+1,099
| +5% | +$80.5K |
|
1823
United Fire Group
UFCS
$1.38B
| $1.58M | ﹤0.01% |
51,932
+631
| +1% | +$18.6K |
|
1824
Concentrix
CNXC
$1.52B
| $1.58M | ﹤0.01% |
34,195
+2,294
| +7% | +$122K |
|
1825
Hillman Solutions
HLMN
$1.69B
| $1.58M | ﹤0.01% |
171,917
+7,682
| +5% | +$69.4K |
|
Similar funds
T. Rowe Price Associates's Q3 2025 Portfolio in Review
As of Q3 2025, T. Rowe Price Associates held 3,142 positions worth $935B, up 5.9% from $883B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
T. Rowe Price Associates's Q3 2025 filing shows 87 new, 2,049 increased, 682 reduced and 98 closed positions. Its largest new stake was Cemex: 19,009,088 shares worth $171M. The largest sale was Amazon, an estimated $3.44B.
By sector, the portfolio is most concentrated in Technology at 36% of assets, up from 35% a quarter earlier, followed by Financials and Consumer Discretionary.
- T. Rowe Price Associates's largest Q3 2025 buy was Cemex: 19,009,088 shares worth $171M.
- T. Rowe Price Associates added most to Arista Networks in Q3 2025, an estimated $4.06B increase.
- T. Rowe Price Associates's biggest Q3 2025 reduction was Amazon, cutting an estimated $3.44B.
- T. Rowe Price Associates fully exited Hess in Q3 2025, selling an estimated $308M.
- T. Rowe Price Associates's ten largest holdings make up 37% of its $935B portfolio in Q3 2025.
- T. Rowe Price Associates opened 87 new positions and closed 98 in Q3 2025.
- T. Rowe Price Associates's portfolio value rose 5.9% quarter-over-quarter to $935B.
Based on T. Rowe Price Associates's 13F filing for Q3 2025, filed 14 Nov 2025.